1. Overall, C. M. and Lopez-Otin, C. (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2, 657–672.
2. Egeblad, M. and Werb, Z. (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2, 161–174.
3. Song, F., Wisithphrom, K., Zhou, J., and Windsor, L. J. (2006) Matrix metalloproteinase dependent and independent collagen degradation. Frontiers Biosci 11, 3100–3120.
4. Fingleton, B. (2007) Matrix metalloproteinases as valid clinical targets. Curr Pharm Design 13, 333–346.
5. Bodey, B., Bodey, J. B., Siegel, S. E., and Kaiser, H. F. (2001) Matrix metalloproteinase expression in malignant melanomas: tumor–extracellular matrix interactions in invasion and metastasis. In Vivo 15, 57–64.